AA
AEON.WS

Ancora Advisors’s AEON Biopharma Inc AEON.WS Stock Holding History

Ancora Advisors’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,589
Closed -$307 – 1949
2023
Q1 		$307 Hold
5,589
– – ﹤0.01% 1786
2022
Q4 		$0 Hold
5,589
– – ﹤0.01% 2095
2022
Q3 		$0 Hold
5,589
– – ﹤0.01% 2268
2022
Q2 		$1K Hold
5,589
– – ﹤0.01% 2144
2022
Q1 		$2K Hold
5,589
– – ﹤0.01% 2176
2021
Q4 		$3K Hold
5,589
– – ﹤0.01% 2156
2021
Q3 		$3K Hold
5,589
– – ﹤0.01% 2012
2021
Q2 		$6K Buy
+5,589
New +$4.24K ﹤0.01% 1669

Other funds holding AEON.WS

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Ancora Advisors's AEON.WS Position: Q2 2023 in Review

Ancora Advisors sold out of AEON Biopharma Inc (AEON.WS) in Q2 2023, closing a stake of 5,589 shares — an estimated $307 sold.

Ancora Advisors first reported a position in AEON.WS in Q2 2021 and held it in 8 quarters. The position peaked at $6K in Q2 2021. 42 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2023.

  • Ancora Advisors reported no remaining AEON Biopharma Inc position as of Q2 2023 after selling out during the quarter.
  • Ancora Advisors sold 5,589 AEON Biopharma Inc shares in Q2 2023, an estimated $307.
  • Ancora Advisors first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 8 quarters.
  • Ancora Advisors's AEON Biopharma Inc position peaked at $6K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.